SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-004231
Filing Date
2023-01-09
Accepted
2023-01-09 08:46:09
Documents
50
Period of Report
2023-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d380757d8k.htm   iXBRL 8-K 34505
2 EX-10.1 d380757dex101.htm EX-10.1 64979
3 EX-99.1 d380757dex991.htm EX-99.1 22930
4 EX-99.2 d380757dex992.htm EX-99.2 33669
8 GRAPHIC g380757ex99_2s10g1.jpg GRAPHIC 417068
9 GRAPHIC g380757ex99_2s11g1.jpg GRAPHIC 318199
10 GRAPHIC g380757ex99_2s12g1.jpg GRAPHIC 334898
11 GRAPHIC g380757ex99_2s13g1.jpg GRAPHIC 197574
12 GRAPHIC g380757ex99_2s14g1.jpg GRAPHIC 161318
13 GRAPHIC g380757ex99_2s15g1.jpg GRAPHIC 280840
14 GRAPHIC g380757ex99_2s16g1.jpg GRAPHIC 239977
15 GRAPHIC g380757ex99_2s17g1.jpg GRAPHIC 241187
16 GRAPHIC g380757ex99_2s18g1.jpg GRAPHIC 256947
17 GRAPHIC g380757ex99_2s19g1.jpg GRAPHIC 179228
18 GRAPHIC g380757ex99_2s1g1.jpg GRAPHIC 113672
19 GRAPHIC g380757ex99_2s20g1.jpg GRAPHIC 167867
20 GRAPHIC g380757ex99_2s21g1.jpg GRAPHIC 308406
21 GRAPHIC g380757ex99_2s22g1.jpg GRAPHIC 282767
22 GRAPHIC g380757ex99_2s23g1.jpg GRAPHIC 114661
23 GRAPHIC g380757ex99_2s24g1.jpg GRAPHIC 251251
24 GRAPHIC g380757ex99_2s25g1.jpg GRAPHIC 343411
25 GRAPHIC g380757ex99_2s26g1.jpg GRAPHIC 272411
26 GRAPHIC g380757ex99_2s27g1.jpg GRAPHIC 117762
27 GRAPHIC g380757ex99_2s28g1.jpg GRAPHIC 162367
28 GRAPHIC g380757ex99_2s29g1.jpg GRAPHIC 229914
29 GRAPHIC g380757ex99_2s2g1.jpg GRAPHIC 525970
30 GRAPHIC g380757ex99_2s30g1.jpg GRAPHIC 329773
31 GRAPHIC g380757ex99_2s31g1.jpg GRAPHIC 311883
32 GRAPHIC g380757ex99_2s32g1.jpg GRAPHIC 132246
33 GRAPHIC g380757ex99_2s33g1.jpg GRAPHIC 260659
34 GRAPHIC g380757ex99_2s3g1.jpg GRAPHIC 311725
35 GRAPHIC g380757ex99_2s4g1.jpg GRAPHIC 340465
36 GRAPHIC g380757ex99_2s5g1.jpg GRAPHIC 293236
37 GRAPHIC g380757ex99_2s6g1.jpg GRAPHIC 277520
38 GRAPHIC g380757ex99_2s7g1.jpg GRAPHIC 182700
39 GRAPHIC g380757ex99_2s8g1.jpg GRAPHIC 291015
40 GRAPHIC g380757ex99_2s9g1.jpg GRAPHIC 263557
41 GRAPHIC g380757g0107073147485.jpg GRAPHIC 3463
42 GRAPHIC g380757img001.jpg GRAPHIC 4683
  Complete submission text file 0001193125-23-004231.txt   12063354

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mirm-20230107.xsd EX-101.SCH 2849
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20230107_lab.xml EX-101.LAB 18736
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20230107_pre.xml EX-101.PRE 11706
44 EXTRACTED XBRL INSTANCE DOCUMENT d380757d8k_htm.xml XML 3472
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 23516785
SIC: 2834 Pharmaceutical Preparations